The Guanajuatense organism will offers the best prices on all products sold as it diversifies its business model Guanajuato/Gto News ISSEG Phar
The Guanajuatense organism will offers the best prices on all products sold as it diversifies its business model
Guanajuato/Gto News
ISSEG Pharmacies has implemented a new wholesale sales model, aiming to offer better prices on all products sold, except for prescription medications, through a pre-quote basis.

This new modality of sales of ISSEG is designed to directly benefit hospitals, MSMEs, schools, and all types of businesses that require efficient and cost-effective supply.

This strategy allows institutions and businesses to access preferential prices, which represents a significant advantage for those who purchase products in volume, such as:
- Private hospitals and clinics
- Micro, small and medium-sized enterprises (MSMEs)
- Public and private education institutions
- Companies from different sectors with supply needs
Conditions for requesting a quote:
- The application must include a minimum of 30 pieces in total, or
- Have a total amount greater than $15,000.00 MXN before the discount

These conditions ensure that quotes reflect the volume necessary to apply to special pricing, protecting both the client’s financial situation and the sustainability of the business model.

To apply, those interested should visit any of the 202 pharmacies and request a wholesale estimate:
- The pharmacy manager will enter your request into the system
- The request is evaluated, and once authorized, the pharmacy will share the special prices with you
- If you accept the quote, the pharmacy will inform you of the time you wish to apply the discount
- The purchase must be made for the total number of products included in the quote
- Upon completion of the sale, the ticket will be sent as proof
This initiative, informed ISSEG, not only benefits customers but also strengthens the State employees’ pension fund by contributing to the growth of ISSEG’s institutional assets.
En Español:



COMMENTS